alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

                                                                   EXHIBIT 11.0

                        ADVANCED MARKETING SERVICES, INC.
                 STATEMENT RE COMPUTATION OF PER SHARE EARNINGS
            (UNAUDITED - AMOUNTS IN THOUSANDS, EXCEPT PER SHARE DATA)


<TABLE>
<CAPTION>
                                                             THREE MONTHS ENDED
                                                           -----------------------
                                                           JUNE 27,       JUNE 28,
                                                             1998           1997
                                                            ------         ------
<S>                                                         <C>           <C>
Net Income                                                  $1,651        $1,415
                                                            ------         ------
                                                            ------         ------
Weighted Average Common and
    Common Share Equivalents:

 Weighted Average Common Shares
    Outstanding                                              5,613         5,518

 Weighted Average Common Share
    Equivalents-Dilutive Stock Options:

        Basic                                                   --            --
                                                            ------         ------
        Diluted                                                206           179
                                                            ------         ------

  Total Weighted Average Common and
    Common Equivalent Shares:

        Basic                                                5,613         5,518
                                                            ------         ------
                                                            ------         ------
        Diluted                                              5,819         5,697
                                                            ------         ------
                                                            ------         ------
Net Income Per Common and
    Common Share Equivalent:
 
        Basic                                               $  .29        $  .26
                                                            ------         ------
                                                            ------         ------
        Diluted                                             $  .28        $  .25
                                                            ------         ------
                                                            ------         ------
</TABLE>

COMMON SHARE EQUIVALENTS (FOR AMS OUTSTANDING STOCK OPTIONS) ARE EXCLUDED FROM
EARNINGS PER SHARE CALCULATIONS WHEN ANTIDILUTIVE.
Exhibit 10.7


 


PERSONAL
GUARANTY AND RECOURSE AGREEMENT


 


This
Personal Guaranty and Recourse Agreement, dated May 3, 2017 (this “Guaranty Agreement”), is by and between
Dean L. Ledger, an individual residing at _____________________________ (the “Guarantor”), and JMJ Financial
(the “Investor”).


 


WHEREAS,
NanoFlex Power Corporation, a Florida corporation (the “Issuer”), is issuing a $500,000 Convertible Promissory
Note (the “Note”) to the Investor as of the date hereof;


 


WHEREAS,
the Guarantor is the Chief Executive Officer and a shareholder of the Issuer; and


 


WHEREAS,
the Guarantor wishes to provide the Investor a full and unconditional personal guaranty of the Note as inducement for the Investor
to enter into the Note and to provide better terms for the Issuer under the Note.


 


NOW,
THEREFORE, the parties agree as follows:


 


1.            Guarantee.
The Guarantor hereby fully and unconditionally personally guarantees the Note and fully and unconditionally personally guarantees
the Issuer's obligation to repurchase the Note. The Guarantor’s guarantee represents a full recourse personal guaranty by
the Guarantor of the Issuer’s obligations under the Note and to repurchase the Note such that, for example, if the Issuer
defaults on the payment or repurchase of the Note, then the Investor has the right to pursue the repurchase amount or the outstanding
principal and interest amount, and any other amounts due under the Note, (i) from the Guarantor directly, with or without first
pursuing the Issuer, or (ii) from the Issuer. The Guarantor understands and agrees that if an event of default occurs under
the Note then the Investor may, at its election, pursue the balance due from Guarantor personally.


 


2.            Non-exclusive
Remedies. The Investor’s election of remedies is not exclusive, and the Investor may choose to pursue more than one
remedy without first exhausting any remedy previously pursued.


 


3.            Governing
Law. This Guaranty Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of
Nevada, without regard to the principles of conflict of laws thereof. Any action brought by any party against the other concerning
the transactions contemplated by this Guaranty Agreement shall be brought only in the state courts of Florida or in the federal
courts located in Miami-Dade County, in the State of Florida. Both the parties and the individuals signing this Guaranty Agreement
agree to submit to the jurisdiction of such courts.


 


4.            Enforceability.
If any provision of this Agreement is held by a court of law to be unenforceable or invalid for any reason, the remaining provisions
of this agreement shall be unaffected by such holding. If the invalidation of any such provision materially alters the agreement
of the parties, then the parties shall immediately adopt new provisions to replace those that were declared invalid.


 


	Guarantor:	 	Investor:
	 	 	 
		 	
	Dean
    L. Ledger	 	JMJ
    Financial / Its Principal
Exhibit 10.1


 


[BANK OF THE WEST LETTERHEAD]


 


 


April 19, 2017


 


 


CONDITIONAL WAIVER LETTER


 


 


H.D.D. LLC


125 Foss Creek Circle


Healdsburg, CA 95448


Attention: Phillip L. Hurst


 


		Re:	Loan and Security Agreement dated July 6, 2015 (the “Agreement”) executed by H.D.D. LLC (the “Borrower”)
and Bank of the West, a California banking corporation (the “Lender”).



 


Dear Mr. Hurst:


 


The Lender has become aware of certain breach of the terms of
the Agreement, which constitute an Event of Default thereunder. The breach is described as follows (references are to section of
the Agreement):


 


4.21(d) EBITDA to Current Portion of Long-Term
Debt plus Interest Expense. Borrower failed to maintain a ratio of (1) EBITDA plus contributions minus unfinanced capital expenditures
minus dividends, withdrawals and distributions to (2) Current Portion of Long-Term Debt plus Interest Expense, of not less than
1.25 to 1.0, measured at the end of each fiscal quarter for fiscal quarter ending 12/31/2016.


 


Except to the extent of this and any prior waiver, the Agreement
shall remain unaltered and in full force and effect. This letter shall not be a waiver of any existing Event of Default or breach
of a covenant unless specified herein, whether now existing or hereafter occurring and whether now known or hereafter discovered.


 


This waiver shall be effective only upon receipt by the
Bank of the enclosed acknowledgment copy executed by the Borrowers along with your payment for the waiver fee in the amount
of $5,000.00. If the foregoing is acceptable, please sign the enclosed copy and return, along with your payment,
alternatively by signing below, you hereby authorize Bank of the West to debit the company’s general account
#027-997189 for the amount due to the undersigned not later than May 10, 2017.


 


Sincerely,


 


Bank of the West,


a California banking corporation


 


 


 


	By: 	/s/ Marina Kremer	 
	 	Marina Kremer, Vice President	 



 




     


     


    

 


ACCEPTANCE


 


 


Borrower accepts the terms and conditions
of this Conditional Waiver Letter and agrees to be bound thereby. Borrower acknowledges that this acceptance constitutes Borrower’s
representation and warranty that Borrower has made no loans or extensions of credit to any person during the current fiscal year.


 


Accepted and Agreed to this     21    
day of April, 2017


 


 


Borrower:


 


H.D.D. LLC


 


	By:	Truett-Hurst, Inc., Manager


 


 


	 	By: 	/s/ Phillip L. Hurst	 
	 	 	Phillip L. Hurst, Chief Executive Officer/Chairman
**EXHIBIT 32.1**





**CERTIFICATION
      OF PRINCIPAL EXECUTIVE OFFICER**





Pursuant
      to Section 906 of the Sarbanes-Oxley Act of 2002




I,
      Keith
      A. Meister, Principal Executive Officer of Icahn Enterprises GP Inc.,
      the General Partner of Icahn Enterprises L.P. (the “Registrant”),
      certify that to the best of my knowledge, based upon a review of the American
      Real Estate Partners, L.P. quarterly report on Form 10-Q for the period
      ended September 30, 2007 of the Registrant (the “Report”):




(1) The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934, as amended; and




(2) The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the
      Registrant.




/s/ Keith
              A MeisterKeith
                A MeisterPrincipal
                Executive Officer and Vice Chairman of the Board of Icahn Enterprises
                G.P.
                Inc., the General Partner of Icahn Enterprises
                L.P.


Date:
      November 8, 2007
# L_2020326DE.01001501.xml

| 8.10.2020 | DE | Amtsblatt der Europäischen Union | L 326/15 |
| --- | --- | --- | --- |

8.10.2020

DE

Amtsblatt der Europäischen Union

L 326/15

---

Berichtigung der Verordnung (EU) 2019/6 des Europäischen Parlaments und des Rates vom 11. Dezember 2018 über Tierarzneimittel und zur Aufhebung der Richtlinie 2001/82/EG

(
  Amtsblatt der Europäischen Union L 4 vom 7. Januar 2019
  )

Seite 81, Artikel 57 Absatz 1:

Anstatt:

| „(1) | Die Mitgliedstaaten erheben einschlägige, vergleichbare Daten zum Verkaufsvolumen und zur Anwendung von bei Tieren angewendeten antimikrobiell wirksamen Arzneimitteln, um insbesondere die direkte und indirekte Bewertung der Anwendung solcher Produkte bei der Lebensmittelerzeugung dienenden Tieren in landwirtschaftlichen Betrieben gemäß diesem Artikel und innerhalb der Fristen nach Absatz 5 zu ermöglichen.“ |
| --- | --- |

„(1)

Die Mitgliedstaaten erheben einschlägige, vergleichbare Daten zum Verkaufsvolumen und zur Anwendung von bei Tieren angewendeten antimikrobiell wirksamen Arzneimitteln, um insbesondere die direkte und indirekte Bewertung der Anwendung solcher Produkte bei der Lebensmittelerzeugung dienenden Tieren in landwirtschaftlichen Betrieben gemäß diesem Artikel und innerhalb der Fristen nach Absatz 5 zu ermöglichen.“

muss es heißen:

| „(1) | Die Mitgliedstaaten erheben einschlägige, vergleichbare Daten zum Verkaufsvolumen und zur Anwendung von bei Tieren angewendeten antimikrobiell wirksamen Arzneimitteln, um insbesondere die direkte und indirekte Bewertung der Anwendung solcher Produkte bei der Lebensmittelerzeugung dienenden Tieren auf der Ebene von landwirtschaftlichen Betrieben gemäß diesem Artikel und innerhalb der Fristen nach Absatz 5 zu ermöglichen.“ |
| --- | --- |

„(1)

Die Mitgliedstaaten erheben einschlägige, vergleichbare Daten zum Verkaufsvolumen und zur Anwendung von bei Tieren angewendeten antimikrobiell wirksamen Arzneimitteln, um insbesondere die direkte und indirekte Bewertung der Anwendung solcher Produkte bei der Lebensmittelerzeugung dienenden Tieren auf der Ebene von landwirtschaftlichen Betrieben gemäß diesem Artikel und innerhalb der Fristen nach Absatz 5 zu ermöglichen.“

---
Editorial Note on Part 73
Editorial Note: Nomenclature changes to part 73 appear at 66 FR 66742, Dec. 27, 2001.

§ 73.1329 Guanine. ( a ) *Identity.* ( 1 ) The color additive guanine is the crystalline material obtained from fish scales and consists principally of the two purines, guanine and hypoxanthine. The guanine content will vary from 75 to 97 percent, and the hypoxanthine will vary from 3 to 25 percent, depending on the particular fish and tissue from which the crystals are derived.
( 2 ) Color additive mixtures for drug use made with guanine may contain only those diluents listed in this subpart as safe and suitable for use in color additive mixtures for coloring externally applied drugs.
( b ) *Specifications.* The color additive guanine shall conform to the following specifications and shall be free from impurities other than those named to the extent that such other impurities may be avoided by good manufacturing practice: Guanine, not less than 75 percent. Hypoxanthine, not more than 25 percent. Ash (ignition at 800 °C), not more than 2 percent. Lead (as Pb), not more than 20 parts per million. Arsenic (as As), not more than 3 parts per million. Assay, not less than 96 percent total purines. Mercury (as Hg), not more than 1 part per million.
( c ) *Uses and restrictions.* Guanine is safe for use in coloring externally applied drugs, including those intended for use in the area of the eye, in amounts consistent with good manufacturing practice.
( d ) *Labeling.* The color additive and any mixture prepared therefrom intended solely or in part for coloring purposes shall bear, in addition to any information required by law, labeling in accordance with § 70.25 of this chapter.
( e ) *Exemption from certification.* Certification of this color additive is not necessary for the protection of the public health, and therefore batches therof are exempt from certification pursuant to section 721(c) of the act.
[42 FR 37537, July 22, 1977]
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7729 Introduced in House (IH)]

<DOC>

118th CONGRESS
  2d Session
                                H. R. 7729

   To amend title 38, United States Code, to expand eligibility for 
headstones, markers, and burial receptacles under the laws administered 
 by the Secretary of Veterans Affairs to certain individuals who died 
                       before November 11, 1998.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             March 19, 2024

Mr. Reschenthaler (for himself, Mr. Deluzio, Mr. Joyce of Pennsylvania, 
      Mr. Meuser, Mr. Kelly of Pennsylvania, and Mr. Thompson of 
Pennsylvania) introduced the following bill; which was referred to the 
                     Committee on Veterans' Affairs

_______________________________________________________________________

                                 A BILL

 
   To amend title 38, United States Code, to expand eligibility for 
headstones, markers, and burial receptacles under the laws administered 
 by the Secretary of Veterans Affairs to certain individuals who died 
                       before November 11, 1998.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Dennis and Lois Krisfalusy Act''.

SEC. 2. EXPANSION OF ELIGIBILITY FOR DEPARTMENT OF VETERANS AFFAIRS 
              HEADSTONES, MARKERS, AND BURIAL RECEPTACLES FOR CERTAIN 
              INDIVIDUALS.

    Section 2306(b)(2) of title 38, United States Code, is amended in 
subparagraphs (B) and (C)--
            (1) by striking ``who dies on or after November 11, 1998,'' 
        each place it appears; and
            (2) by striking ``October 1, 2024'' each place it appears 
        and inserting ``October 1, 2034''.
                                 <all>
```
Exhibit 34.6



LOGO

Report of Independent Registered Public Accounting Firm

Tothe Board of Directors and shareholders of CoreLogic, Inc.:

We have examined managements assertion, included in the accompanying Report on Assessment of Compliance, that CoreLogic Commercial Real Estate Services,
Inc. (the Company), a subsidiary of CoreLogic, Inc. complied with the servicing criteria set forth in Item 1122(d) of the Securities and Exchange Commissions Regulation AB for all loans for commercial mortgage loan outsourcing
customers for which the Company served as the commercial tax service provider (the Platform), as of December 31, 2016 and for the year then ended, only including 1122(d)(1)(iv), 1122(d)(2)(ii), 1122(d)(2)(v), 1122(d)(2)(vi),
1122(d)(2)(vii), 1122(d)(4)(xi), 1122(d)(4)(xii) and 1122(d)(4)(xiii), which the Company has determined are applicable to the servicing activities performed by it with respect to the Platform. Management is responsible for the Companys
compliance with the servicing criteria. Our responsibility is to express an opinion on managements assertion based on our examination.

Our
examination was conducted in accordance with attestation standards of the Public Company Accounting Oversight Board (United States) and, accordingly, included examining, on a test basis, evidence about the Companys compliance with the
applicable servicing criteria and performing such other procedures as we considered necessary in the circumstances. Our examination included testing of selected servicing activities related to the Platform, and determining whether the Company
performed those selected activities in compliance with the applicable servicing criteria. Our procedures were limited to the selected servicing activities performed by the Company during the period covered by this report. Our procedures were not
designed to detect noncompliance arising from errors that may have occurred prior to or subsequent to our tests that may have affected the balances or amounts calculated or reported by the Company during the period covered by this report. We believe
that our examination provides a reasonable basis for our opinion. Our examination does not provide a legal determination on the Companys compliance with the servicing criteria.

In our opinion, managements assertion that the Company complied with the aforementioned applicable servicing criteria as of and for the year ended
December 31, 2016 for all loans for commercial mortgage loan outsourcing customers for which the Company served as the commercial tax service provider is fairly stated, in all material respects.



LOGO

February 6, 2017





PricewaterhouseCoopers LLP, 2001 Ross Avenue, Suite 1800, Dallas TX 75201-2997

T: 214-746-6500, F: 214-712-6660,www.pwc.com
**Exhibit32.1**

 

**CERTIFICATIONOF PERIODIC REPORT**

 

I, William W. Hunt, President and Chief Executive Officer of PennTreaty American Corporation, certify, pursuant to Section 906 of theSarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

 

(1) the Quarterly Report on Form 10-Q of the Company for the quarterlyperiod ended June 30, 2003 (the “Report’’) fully complies with the requirementsof Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78mor 78o(d)); and

 

(2) the information contained in the Report fairly presents, in allmaterial respects, the financial condition and results of operations of theCompany.

 
| Date:  August 11, 2003 | /s/  William W. Hunt                   |   |
|-----------------------------|----------------------------------------|--------|
|                        | William  W. Hunt                       |
|                        | President  and Chief Executive Officer |

 

1

----
<TABLE> <S> <C>

<ARTICLE> 9

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                       8,031,055
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                               575,290
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                 25,691,141
<INVESTMENTS-CARRYING>                       1,097,629
<INVESTMENTS-MARKET>                         1,035,343
<LOANS>                                     67,574,756
<ALLOWANCE>                                    842,328
<TOTAL-ASSETS>                             108,469,732
<DEPOSITS>                                  94,824,047
<SHORT-TERM>                                 5,821,090
<LIABILITIES-OTHER>                            944,656
<LONG-TERM>                                  2,790,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         5,390
<OTHER-SE>                                   4,084,549
<TOTAL-LIABILITIES-AND-EQUITY>             108,469,732
<INTEREST-LOAN>                              6,082,587
<INTEREST-INVEST>                            1,719,100
<INTEREST-OTHER>                               102,471
<INTEREST-TOTAL>                             7,904,158
<INTEREST-DEPOSIT>                           3,960,862
<INTEREST-EXPENSE>                           4,313,852
<INTEREST-INCOME-NET>                        3,590,306
<LOAN-LOSSES>                                  240,000
<SECURITIES-GAINS>                              40,742
<EXPENSE-OTHER>                              2,659,046
<INCOME-PRETAX>                              1,072,644
<INCOME-PRE-EXTRAORDINARY>                     710,256
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   710,256
<EPS-BASIC>                                       1.32
<EPS-DILUTED>                                     1.32
<YIELD-ACTUAL>                                    8.37
<LOANS-NON>                                    264,348
<LOANS-PAST>                                   221,180
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                               810,563
<CHARGE-OFFS>                                  215,341
<RECOVERIES>                                     7,106
<ALLOWANCE-CLOSE>                              842,328
<ALLOWANCE-DOMESTIC>                           842,328
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>